| Title |
Trends in Insulin Initiation and Treatment Intensification Among Patients with Type 2 Diabetes
|
|---|---|
| Published in |
Journal of General Internal Medicine, October 2013
|
| DOI | 10.1007/s11606-013-2643-6 |
| Pubmed ID | |
| Authors |
Amanda R. Patrick, Michael A. Fischer, Niteesh K. Choudhry, William H. Shrank, John D. Seeger, Jun Liu, Jerry Avorn, Jennifer M. Polinski |
| Abstract |
Many patients with type 2 diabetes eventually require insulin, yet little is known about the patterns and quality of pharmacologic care received following insulin initiation. Guidelines from the American Diabetes Association and the European Association for the Study of Diabetes recommend that insulin secretagogues such as sulfonylureas be discontinued at the time of insulin initiation to reduce the risk of hypoglycemia, and that treatment be intensified if HbA1c levels remain above-target 3 months after insulin initiation. |
Mendeley readers
The data shown below were compiled from readership statistics for 60 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1 | 2% |
| Denmark | 1 | 2% |
| Unknown | 58 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 9 | 15% |
| Student > Postgraduate | 8 | 13% |
| Other | 7 | 12% |
| Student > Bachelor | 7 | 12% |
| Researcher | 6 | 10% |
| Other | 13 | 22% |
| Unknown | 10 | 17% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 22 | 37% |
| Nursing and Health Professions | 7 | 12% |
| Biochemistry, Genetics and Molecular Biology | 3 | 5% |
| Agricultural and Biological Sciences | 3 | 5% |
| Pharmacology, Toxicology and Pharmaceutical Science | 3 | 5% |
| Other | 10 | 17% |
| Unknown | 12 | 20% |